Company profile: Sphingotec
1.1 - Company Overview
Company description
- Provider of in vitro diagnostic solutions and proprietary blood-based protein biomarkers for acute medical conditions, including sphingotestยฎ penKidยฎ for kidney function and acute kidney injury, sphingotestยฎ bio-ADMยฎ for endothelial function, the Nexus IB10 portable immunoassay system, CE IVD microtiter plate assays, biomarker out-licensing, and customized testing services.
Products and services
- Nexus IB10: An automated, portable immunoassay system that delivers rapid testing of proprietary blood-based protein biomarkers for acute medical conditions, supporting diagnosis, prediction, and monitoring in critical care
- Sphingotestยฎ bio-ADMยฎ: A proprietary blood-based protein biomarker that enables real-time assessment of endothelial function, aiding detection and management of shock and heart failure in acute care
- Sphingotestยฎ penKidยฎ: A blood-based protein biomarker that quantifies kidney function, aiding diagnosis and monitoring of acute kidney injury in critical care
Key contacts
๐
๐
Financial details
๐
1.2 - Competitors and similar companies to Sphingotec
Zevacor
HQ: United States
Website
- Description: Provider of PET and SPECT radiopharmaceuticals, developing, manufacturing, and distributing compounds for PET and SPECT imaging to aid in the diagnosis, monitoring, and management of medical conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Zevacor company profile โ
Immunetics
HQ: United States
Website
- Description: Provider of immunoassay and molecular probe kits and instruments for the diagnosis of infectious diseases, including the Miniblotter instrument system for western blot, spoligotyping, and multi-probe membrane assays, as well as a cell adhesion flow chamber for cell-cell interaction studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Immunetics company profile โ
Sebia
HQ: United States
Website
- Description: Provider of clinical protein electrophoresis equipment and reagents for in-vitro diagnostic (IVD) testing. Systems analyze proteins to screen and monitor diseases and conditions, primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes, and Hemoglobinopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full Sebia company profile โ
DCS Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic devices as a pharmaceutical firm, specializing in the sale and development of devices for human use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full DCS Diagnostics company profile โ
DRG International
HQ: United States
Website
- Description: Provider of clinical diagnostic and research ELISAs with distributors, and manufacturer of the DRG:HYBRiD-XLรยฎ, a fully automated analyzer for Immunoassays and Clinical Chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: โโโโโ
- Total funding raised: $โโโm
- Backers: โโโโโโโโโโ
- Acquisitions: โโ
View full DRG International company profile โ
๐
2.M&A buyers
2.1 Potential strategic acquirers in the sector
๐
๐
๐
๐
View all strategic buyers with complete profiles
Start Free Trial โ
2.2 - Strategic buyer groups for Sphingotec
๐
Buyer group 1: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐
Buyer group 2: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐
Buyer group 3: โโโโโโโโ โโโโโโโโ
โโ companies
Description: โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ โโโโโโโโ
Key Products: โโโโโโโโ, โโโโโโโโ, โโโโโโโโ, โโโโโโโโ
๐
View all companies in this group
Request Free Trial Now โ
๐ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sphingotec
2.2 - Growth funds investing in similar companies to Sphingotec
๐
View all growth equity funds with complete profiles
Start Free Trial โ
4 - Top valuation comps for Sphingotec
4.2 - Public trading comparable groups for Sphingotec
๐ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ